Domov › Rak (vse vrste) › Kalifornija › San Francisco
Klinične študije za Rak (vse vrste) v San Francisco, CA
35 študij za Rak (vse vrste) išče udeležence na lokacijah v San Francisco in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
PediRISE Feasibility
Vključevanje udeležencev
- University of California San Francisco, San Francisco
Distance-Based Exercise to Preserve Function and Prevent Disability
Vključevanje udeležencev
- Kaiser Permanente-San Francisco, San Francisco
Intratumoral N17350 in Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- University of California, San Francisco, San Francisco
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Vključevanje udeležencevFaza 2
- Kaiser Permanente - South San Francisco Medical Center, San Francisco
- California Pacific Medical Center Research Institute, San Francisco
- Kaiser Permanente - San Francisco Medical Center, San Francisco
- in še 1
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Vključevanje udeležencevFaza 2/3
- University of California, San Francisco- California, San Francisco
Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
Vključevanje udeležencevOpazovalna študija
- University of California, San Francisco, San Francisco
Prostate Active Surveillance Study
Vključevanje udeležencevOpazovalna študija
- Veterans Affairs San Francisco Health Care System, San Francisco
- University of California, San Francisco, San Francisco
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Vključevanje udeležencevFaza 1
- UCSF, San Francisco
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Vključevanje udeležencevFaza 1
- UCSF, San Francisco
Project: Every Child for Younger Patients With Cancer
Vključevanje udeležencevOpazovalna študija
- UCSF Medical Center-Mission Bay, San Francisco
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1/2
- University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco
International Rare Brain Tumor Registry
Vključevanje udeležencevOpazovalna študija
- University of California San Francisco, San Francisco
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Vključevanje udeležencevFaza 3
- California Pacific Medical Center-Pacific Campus, San Francisco
- Kaiser Permanente-San Francisco, San Francisco
GOLD: Brief Intervention to Reduce Anxiety and Promote Resilience in Families of Youth With Cancer
Vključevanje udeležencev
- Stanford Cancer Institute, San Francisco
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
Vključevanje udeležencevFaza 2
- The Unviersity of California, San Francisco (UCSF), San Francisco
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Vključevanje udeležencevFaza 2
- 014, San Francisco
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Vključevanje udeležencevFaza 1
- University of California San Francisco, San Francisco
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- UCSF Medical Center at Mission Bay, San Francisco
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Vključevanje udeležencevFaza 1/2
- UCSF Medical Center - Mission Bay, San Francisco
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Childhood Cancer Survivor Study
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- University of California-San Francisco, San Francisco
Multisite Implementation of COMPRENDO
Vključevanje udeležencevVabljeni zdravi prostovoljci
- University of California San Francisco Benioff Children's Hospitals, San Francisco
Galleri® in the Medicare Population.
Vključevanje udeležencevVabljeni zdravi prostovoljci
- University of California San Francisco Health System, San Francisco
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Vključevanje udeležencevFaza 2
- University of California San Francisco (UCSF), San Francisco
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Vključevanje udeležencev
- Zuckerberg San Francisco General, San Francisco
- Kaiser Foundation Research Institute, San Francisco
- University of San Francisco, San Francisco
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Vključevanje udeležencevFaza 1
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade Glioma
Vključevanje udeležencev
- University of California, San Francisco, San Francisco
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
Vključevanje udeležencevFaza 1/2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Primary Tumor Research and Outcomes Network
Vključevanje udeležencevOpazovalna študija
- UCSF Medical Center, San Francisco
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
Vključevanje udeležencevOpazovalna študija
- University of California San Francisco, San Francisco
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Vključevanje udeležencevFaza 2
- University of California, San Francisco, San Francisco
ChangeGradients: Promoting Adolescent Health Behavior Change
Vključevanje udeležencevVabljeni zdravi prostovoljci
- University of California San Francisco Adolescent and Young Adult Medicine Clinic, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, San Francisco
A Study of NX-1607 in Adults With Advanced Malignancies
Vključevanje udeležencevFaza 1
- University of California, San Francisco, San Francisco
Študije za Rak (vse vrste) v drugih mestih
- Houston, TX121 študij
- New York City, NY109 študij
- Boston, MA85 študij
- Los Angeles, CA74 študij
- Nashville, TN65 študij
- Philadelphia, PA59 študij
- Washington, DC58 študij
- Durham, NC58 študij
- Chicago, IL51 študij
- Atlanta, GA49 študij
- Seattle, WA49 študij
- Arlington, VA48 študij
Druge študije v San Francisco
- Rak prostate45 študij
- Rak dojke43 študij
- Nemalicelični pljučni rak36 študij
- Srčno popuščanje29 študij
- Metastatski rak28 študij
- Rak pljuč22 študij
- Melanom22 študij
- Rak trebušne slinavke20 študij
- Rak jajčnikov19 študij
- Kolorektalni rak18 študij
- Srčno-žilne bolezni18 študij
- Glioblastom17 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.